Medications

FDA issues multiple sclerosis drug alert

(HealthDay) -- The multiple sclerosis drug Gilenya (fingolimod) should not be given to patients with certain pre-existing or recent heart conditions or stroke, or those taking certain medications to correct heart rhythm problems, ...

Cardiology

Researchers find possible cardiovascular risk with NSAID use

A new study from Rhode Island Hospital researchers suggests that controlling cholesterol may be important for heart health in patients who are taking non-steroidal anti-inflammatory drugs (NSAIDs) such as naproxen. The findings ...

Diseases, Conditions, Syndromes

How bone marrow contributes to the development of atherosclerosis

The activation of the bone marrow appears to play a key role in the origin and development of atherosclerosis, the pathological process underlying cardiovascular conditions such as myocardial infarction and stroke. A study ...

page 13 from 23